menu search

IPA / ImmunoPrecise Antibodies Ltd. (IPA) CEO Jennifer Bath on Q3 2022 Results - Earnings Call Transcript

ImmunoPrecise Antibodies Ltd. (IPA) CEO Jennifer Bath on Q3 2022 Results - Earnings Call Transcript
ImmunoPrecise Antibodies Ltd. (IPA) CEO Jennifer Bath on Q3 2022 Results - Earnings Call Transcript Read More
Posted: Mar 16 2022, 14:56
Author Name: Seeking Alpha
Views: 112572

IPA News  

ImmunoPrecise Antibodies Ltd. (IPA) Reports Q3 Loss, Lags Revenue Estimates

By Zacks Investment Research
March 16, 2023

ImmunoPrecise Antibodies Ltd. (IPA) Reports Q3 Loss, Lags Revenue Estimates

ImmunoPrecise Antibodies Ltd. (IPA) delivered earnings and revenue surprises of -16.67% and 6.19%, respectively, for the quarter ended January 2023. more_horizontal

IPA to Report Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2023 on March 16, 2023

By Business Wire
March 7, 2023

IPA to Report Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2023 on March 16, 2023

VICTORIA, British Columbia--(BUSINESS WIRE)---- $IPA #AI--IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company” or “IPA”) (NASDAQ: IPA), an advan more_horizontal

ImmunoPrecise Antibodies Ltd. (IPA) Q2 2023 Earnings Call Transcript

By Seeking Alpha
December 15, 2022

ImmunoPrecise Antibodies Ltd. (IPA) Q2 2023 Earnings Call Transcript

ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA ) Q2 2023 Earnings Conference Call December 15, 2022 10:30 AM ET Company Participants Jennifer Bath – Chie more_horizontal

IPA to Report Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2023 on December 15, 2022

By Business Wire
December 5, 2022

IPA to Report Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2023 on December 15, 2022

VICTORIA, British Columbia--( BUSINESS WIRE )--IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company” or “IPA”) (NASDAQ: IPA), an advanced biother more_horizontal

IPA to Report Financial Results and Recent Business Highlights for Fourth Quarter and Full Fiscal Year 2022 on July 29, 2022

By Business Wire
July 26, 2022

IPA to Report Financial Results and Recent Business Highlights for Fourth Quarter and Full Fiscal Year 2022 on July 29, 2022

VICTORIA, British Columbia--(BUSINESS WIRE)---- $IPA #AI--IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company” or “IPA”) (NASDAQ: IPA) (TSXV: IP more_horizontal

ImmunoPrecise Antibodies Ltd. (IPA) CEO Jennifer Bath on Q3 2022 Results - Earnings Call Transcript

By Seeking Alpha
March 16, 2022

ImmunoPrecise Antibodies Ltd. (IPA) CEO Jennifer Bath on Q3 2022 Results - Earnings Call Transcript

ImmunoPrecise Antibodies Ltd. (IPA) CEO Jennifer Bath on Q3 2022 Results - Earnings Call Transcript more_horizontal

ImmunoPrecise Sets Third Quarter Fiscal 2022 Financial Results and Recent Business Highlights Conference Call for Wednesday, March 16th at 10:30 a.m. ET

By Business Wire
March 8, 2022

ImmunoPrecise Sets Third Quarter Fiscal 2022 Financial Results and Recent Business Highlights Conference Call for Wednesday, March 16th at 10:30 a.m. ET

VICTORIA, British Columbia--(BUSINESS WIRE)---- $IPA #Deltavariant--IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (NASDAQ: IPA) (TSX VENTURE: more_horizontal

ImmunoPrecise's COVID-19 Antibody Cocktail Shows Neutralization Activity Against Omicron

By Benzinga
January 31, 2022

ImmunoPrecise's COVID-19 Antibody Cocktail Shows Neutralization Activity Against Omicron

Immunoprecise Antibodies Ltd IPA has released preclinical data for the PolyTope TATX-03 COVID-19 antibody cocktail. [ALERT] Nic Chahine shares his Be more_horizontal


Search within

Pages Search Results: